Results 231 to 240 of about 18,729 (264)
Some of the next articles are maybe not open access.

Endothelin receptor antagonists‐induced hepatotoxicity

Internal Medicine Journal, 2013
D, Macías Saint-Gerons   +3 more
openaire   +2 more sources

Comparison of the dissolution and pharmacokinetic profiles of two galenical formulations of the endothelin receptor antagonist macitentan.

European Journal of Pharmaceutical Sciences, 2009
O. Kummer   +7 more
semanticscholar   +1 more source

Sitaxsentan, a selective endothelin-A receptor antagonist for the treatment of pulmonary arterial hypertension

Expert Opinion on Investigational Drugs, 2004
Evelyn M Horn, Allison C Widlitz
exaly  

Pathophysiological role of endothelin revealed by the first orally active endothelin receptor antagonist

Nature, 1993
M. Clozel   +10 more
semanticscholar   +1 more source

Structure-activity relationships of an endothelin ETA receptor antagonist, 50–235, and its derivatives

European Journal of Pharmacology, 1993
Shin-Ichi Mihara   +2 more
exaly  

Pharmacology of Macitentan, an Orally Active Tissue-Targeting Dual Endothelin Receptor Antagonist

Journal of Pharmacology and Experimental Therapeutics, 2008
M. Iglarz   +13 more
semanticscholar   +1 more source

Endothelin receptor antagonists and cerebral vasospasm

Clinical Autonomic Research, 2004
Michael, Zimmermann, Volker, Seifert
openaire   +2 more sources

Endothelin type A receptor antagonist attenuates placental ischemia–induced hypertension and uterine vascular resistance

American Journal of Obstetrics and Gynecology, 2011
Eric M George   +2 more
exaly  

Home - About - Disclaimer - Privacy